吸入化疗不良反应:机制及保护方法。

Pub Date : 2020-01-16 DOI:10.2217/lmt-2019-0007
Chrysanthi Sardeli, Paul Zarogoulidis, Christoforos Kosmidis, Aikaterini Amaniti, Athanasios Katsaounis, Dimitrios Giannakidis, Charilaos Koulouris, Wolfgang Hohenforst-Schmidt, Haidong Huang, Chong Bai, Nikolaos Michalopoulos, Kosmas Tsakiridis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantina Mponiou, Anastasios Vagionas, Alexandru Marian Goganau, Isaak Kesisoglou, Konstantinos Sapalidis
{"title":"吸入化疗不良反应:机制及保护方法。","authors":"Chrysanthi Sardeli,&nbsp;Paul Zarogoulidis,&nbsp;Christoforos Kosmidis,&nbsp;Aikaterini Amaniti,&nbsp;Athanasios Katsaounis,&nbsp;Dimitrios Giannakidis,&nbsp;Charilaos Koulouris,&nbsp;Wolfgang Hohenforst-Schmidt,&nbsp;Haidong Huang,&nbsp;Chong Bai,&nbsp;Nikolaos Michalopoulos,&nbsp;Kosmas Tsakiridis,&nbsp;Konstantinos Romanidis,&nbsp;Panagoula Oikonomou,&nbsp;Konstantina Mponiou,&nbsp;Anastasios Vagionas,&nbsp;Alexandru Marian Goganau,&nbsp;Isaak Kesisoglou,&nbsp;Konstantinos Sapalidis","doi":"10.2217/lmt-2019-0007","DOIUrl":null,"url":null,"abstract":"<p><p>Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inhaled administration is used as a local route in order to reduce the systemic adverse effects; however, this treatment modality has its own adverse effects. In this mini review, we present drugs that were administered as nebulized droplets or dry powder aerosols for non-small-cell lung cancer. We present the adverse effects and methods to overcome them.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/lmt-2019-0007","citationCount":"13","resultStr":"{\"title\":\"Inhaled chemotherapy adverse effects: mechanisms and protection methods.\",\"authors\":\"Chrysanthi Sardeli,&nbsp;Paul Zarogoulidis,&nbsp;Christoforos Kosmidis,&nbsp;Aikaterini Amaniti,&nbsp;Athanasios Katsaounis,&nbsp;Dimitrios Giannakidis,&nbsp;Charilaos Koulouris,&nbsp;Wolfgang Hohenforst-Schmidt,&nbsp;Haidong Huang,&nbsp;Chong Bai,&nbsp;Nikolaos Michalopoulos,&nbsp;Kosmas Tsakiridis,&nbsp;Konstantinos Romanidis,&nbsp;Panagoula Oikonomou,&nbsp;Konstantina Mponiou,&nbsp;Anastasios Vagionas,&nbsp;Alexandru Marian Goganau,&nbsp;Isaak Kesisoglou,&nbsp;Konstantinos Sapalidis\",\"doi\":\"10.2217/lmt-2019-0007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inhaled administration is used as a local route in order to reduce the systemic adverse effects; however, this treatment modality has its own adverse effects. In this mini review, we present drugs that were administered as nebulized droplets or dry powder aerosols for non-small-cell lung cancer. We present the adverse effects and methods to overcome them.</p>\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2020-01-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/lmt-2019-0007\",\"citationCount\":\"13\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/lmt-2019-0007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/lmt-2019-0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13

摘要

由于缺乏症状,肺癌的诊断仍处于晚期。虽然有新的治疗方法,但许多患者仍然接受化疗。为了减少与化疗相关的不良反应,研究人员对吸入铂类似物进行了研究。吸入给药作为局部途径,以减少全身不良反应;然而,这种治疗方式有其自身的副作用。在这篇迷你综述中,我们介绍了用于治疗非小细胞肺癌的雾化液滴或干粉气溶胶的药物。我们提出了不良影响和克服它们的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Inhaled chemotherapy adverse effects: mechanisms and protection methods.

Inhaled chemotherapy adverse effects: mechanisms and protection methods.

分享
查看原文
Inhaled chemotherapy adverse effects: mechanisms and protection methods.

Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inhaled administration is used as a local route in order to reduce the systemic adverse effects; however, this treatment modality has its own adverse effects. In this mini review, we present drugs that were administered as nebulized droplets or dry powder aerosols for non-small-cell lung cancer. We present the adverse effects and methods to overcome them.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信